BSETitan Biotech LtdMediumNegative
Announced Fri, 25 Jul · 11:27 IST

The legal notice invoking arbitraiton received from a private limited company supplying software upgradation services to company. The dispute is regarding payment of disputed outstanding ....

Regulatory & Legal View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Titan Biotech has disclosed receiving an arbitration notice on 23 July 2025 from NGenious Solutions Private Limited, an ERP software vendor. The vendor is claiming recovery of disputed outstanding dues of about Rs. 10.62 lakh plus GST, which includes a balance of Rs. 9.13 lakh, compounded interest of around Rs. 98,490, and compensation of Rs. 50,000. Titan Biotech says the software had persistent errors and bugs, which were flagged but not fixed, leading the company to terminate the agreement and withhold payment. The company tried to resolve the issue amicably but the vendor chose to invoke arbitration. The matter also names the company's directors and key managerial personnel.

Likely market impact

The disputed amount is relatively small for a listed company and is unlikely to meaningfully affect Titan Biotech's financials, though legal costs and management time will add up. Shareholders should watch for updates on the arbitration outcome, as an adverse ruling would result in a one-time payout, while a favourable one would have no material impact.